| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
5,513 |
4,843 |
$264K |
| Z7502 |
|
5,078 |
4,942 |
$196K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,036 |
1,756 |
$105K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,831 |
6,423 |
$80K |
| 80053 |
Comprehensive metabolic panel |
5,591 |
5,198 |
$76K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,316 |
2,267 |
$66K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,078 |
961 |
$66K |
| Z7610 |
|
6,038 |
3,191 |
$61K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,479 |
2,423 |
$56K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
520 |
458 |
$44K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,964 |
377 |
$44K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
609 |
556 |
$38K |
| 80061 |
Lipid panel |
2,411 |
2,365 |
$38K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
111 |
73 |
$36K |
| X3908 |
|
1,152 |
394 |
$35K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,529 |
2,472 |
$32K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
415 |
378 |
$28K |
| 84439 |
|
2,224 |
2,180 |
$26K |
| 97139 |
|
1,013 |
180 |
$25K |
| 70450 |
Computed tomography, head or brain; without contrast material |
140 |
135 |
$24K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
267 |
244 |
$21K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
724 |
677 |
$18K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
615 |
538 |
$16K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
92 |
90 |
$15K |
| 71046 |
Radiologic examination, chest; 2 views |
727 |
690 |
$14K |
| 99499 |
|
326 |
285 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
572 |
520 |
$13K |
| 97750 |
|
287 |
261 |
$11K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,758 |
1,468 |
$10K |
| 87631 |
|
168 |
167 |
$10K |
| J3490 |
Unclassified drugs |
5,180 |
2,188 |
$9K |
| X3910 |
|
551 |
196 |
$8K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
308 |
299 |
$7K |
| 81001 |
|
1,533 |
1,453 |
$7K |
| 83690 |
|
496 |
443 |
$5K |
| 87070 |
|
388 |
368 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
543 |
506 |
$4K |
| 87430 |
|
313 |
302 |
$4K |
| 84153 |
|
148 |
132 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
85 |
80 |
$4K |
| 81003 |
|
1,343 |
1,289 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
40 |
40 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,175 |
1,005 |
$3K |
| 84484 |
|
234 |
214 |
$3K |
| X3920 |
|
53 |
53 |
$3K |
| 81025 |
|
351 |
333 |
$3K |
| 82607 |
|
68 |
67 |
$2K |
| 99070 |
|
1,079 |
590 |
$2K |
| 74022 |
|
44 |
40 |
$2K |
| 87486 |
|
48 |
44 |
$2K |
| 87581 |
|
48 |
44 |
$2K |
| 82550 |
|
195 |
184 |
$2K |
| 83605 |
|
86 |
79 |
$1K |
| 73564 |
|
48 |
43 |
$1K |
| 85610 |
|
226 |
206 |
$1K |
| 87400 |
|
201 |
199 |
$908.66 |
| 85651 |
|
174 |
160 |
$840.85 |
| 82270 |
|
199 |
185 |
$769.26 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
561 |
481 |
$742.09 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
66 |
66 |
$730.54 |
| 82553 |
|
40 |
39 |
$631.22 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
14 |
14 |
$596.52 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
26 |
25 |
$562.75 |
| 73030 |
|
17 |
14 |
$411.36 |
| 85730 |
|
48 |
40 |
$405.25 |
| 71045 |
Radiologic examination, chest; single view |
41 |
38 |
$368.69 |
| 71020 |
|
14 |
14 |
$349.58 |
| 85379 |
|
27 |
25 |
$336.89 |
| 73610 |
|
12 |
12 |
$303.43 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
100 |
75 |
$256.75 |
| 80306 |
|
16 |
16 |
$255.36 |
| 73630 |
|
14 |
13 |
$245.20 |
| 0270 |
|
63 |
40 |
$219.34 |
| 84145 |
|
12 |
12 |
$212.35 |
| 87186 |
|
16 |
16 |
$182.99 |
| 84703 |
|
14 |
14 |
$158.96 |
| 87040 |
|
13 |
12 |
$150.85 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
29 |
25 |
$84.70 |
| J2060 |
Injection, lorazepam, 2 mg |
53 |
43 |
$79.39 |
| 84550 |
|
13 |
13 |
$74.18 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
12 |
12 |
$16.46 |